Zai Lab (ZLAB) EBIT Margin (2019 - 2026)
Zai Lab (ZLAB) posted quarterly EBIT Margin of 69.66% for Q1 2026, down 1678.0% year-on-year from 4.41% in Q1 2025, and down 28.06% on a QoQ basis from 54.39% in Q4 2025.
Zai Lab (ZLAB) EBIT Margin (2019 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported EBIT Margin for 8 consecutive years, with 69.66% the latest figure, recorded in Q1 2026.
- Quarterly EBIT Margin fell 1678.0% year-over-year to 69.66% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 53.5% (up 1059.0% YoY) and the FY2025 annual result came in at 49.86%, up 2085.0% from the prior year.
- EBIT Margin eased to 69.66% in Q1 2026 per ZLAB's latest filing, from 54.39% in the prior quarter.
- Over the last five years, EBIT Margin for ZLAB reached as high as 42.05% in Q3 2025 and fell as low as 223.47% in Q3 2022.
- A 5-year average of 109.3% and a median of 80.68% in 2024 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin soared 95893 bps — and 2023, when it sank 3292 bps.
- Year by year, EBIT Margin stood at 155.42% in 2022, then dropped by 21 bps to 188.34% in 2023, then soared by 67 bps to 62.25% in 2024, then rose by 13 bps to 54.39% in 2025, then fell by 28 bps to 69.66% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 69.66%, 54.39%, and 42.05% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -69.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.66% |
| Dec 31, 2025 | -54.39% |
| Sep 30, 2025 | -42.05% |
| Jun 30, 2025 | -49.91% |
| Mar 31, 2025 | -52.88% |
| Dec 31, 2024 | -62.25% |
| Sep 30, 2024 | -66.35% |
| Jun 30, 2024 | -75.68% |
| Mar 31, 2024 | -80.68% |
| Dec 31, 2023 | -188.34% |
| Sep 30, 2023 | -120.72% |
| Jun 30, 2023 | -129.97% |
| Mar 31, 2023 | -110.71% |
| Dec 31, 2022 | -155.42% |
| Sep 30, 2022 | -223.47% |
| Jun 30, 2022 | -204.91% |
| Mar 31, 2022 | -170.71% |
| Dec 31, 2021 | -498.58% |
| Sep 30, 2021 | -193.04% |
| Jun 30, 2021 | -461.81% |